Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy

Exclusion Criteria

• •Severe liver or renal dysfunction or hemorrhagic diseases not suitable for PCI.
• •Severe cerebral ischemic stroke or cerebral hemorrhage within 6 month.
• •History with malignant disease within 5 y of inclusion or suspected malignity
• •Severe heart failure (NYHA functional classification IV)
• •Diminished functional capacity for other reasons such as COPD, alcoholic cardiomyopathy, or viral myocarditis
• •Clinical significant anemia, leukopenia, leukocytosis,or thrombocythemia
• •Clinical significant abnormal prothrombin or partial thromboplastin time or anticoagulation treatment that cannot be paused during treatment
• •Patients with reduced immune response or treated with immunosuppressive medication
• •Combined with severe infectious diseases
• •Pregnant or fertile women
• •Socially and mentally disabilities